Azenta outlines 3% to 5% organic revenue growth and 300bps margin expansion for 2026 amid macro uncertainty
Source: SeekingAlpha
2026-02-04 14:01:57 ET
More on Azenta
- Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
- Azenta, Inc. (AZTA) Analyst/Investor Day Transcript
- Azenta, Inc. (AZTA) Analyst/Investor Day - Slideshow
- Azenta reports mixed Q1 results; reaffirms FY26 outlook
- Azenta Q1 2026 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Azenta outlines 3% to 5% organic revenue growth and 300bps margin expansion for 2026 amid macro uncertainty
Azenta Inc.
NASDAQ: AZTA
AZTA Trading
-4.5% G/L:
$22.73 Last:
505,137 Volume:
$23.67 Open:
AZTA Latest News
March 04, 2026 09:11:00 am
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
February 24, 2026 04:05:00 pm
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
AZTA Stock Data
$1,381,385,255
41,040,822
0.12%
106
N/A
Biotechnology & Life Sciences
Healthcare
US
Burlington
